U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07551713) titled 'Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects' on April 20.
Brief Summary: The test formulation (Lidocaine and Prilocaine Cream, Haisco Pharmaceutical Group Co., Ltd.) and the reference formulation (EMLA(R), AstraZeneca) were applied to healthy adult subjects under fasting conditions to evaluate the bioequivalence and safety of the two formulations
Study Start Date: June 11, 2020
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Tested Lidocaine and Prilocaine Cream
Under fasting conditions, 15 g of the test formulation (Lidocaine and Prilocaine Cream, Haisco Pharmaceutica...